Clearside Biomedical files for Chapter 11 bankruptcy; Nasdaq delisting effective Dec 1

Clearside Biomedical, Inc.

Filed voluntary Chapter 11 petition on Nov 23, 2025 in Delaware (Case No. 25-12109).
Nasdaq delisting notice received; trading suspended Dec 1, moving to OTC under symbol CLSDQ.
Company intends to sell substantially all assets through a Section 363 auction.
First-day motions filed to continue normal operations during the bankruptcy process.
Assets include SCS Microinjector platform, CLS-AX program, and multiple licensing deals.

item 1.03 item 3.01 item 7.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001193125-25-297177
form_type: 8-K
ticker: CLSDQ
cik: 0001539029
company_name: Clearside Biomedical, Inc.
filed_at: 2025-11-25T23:59:59+00:00
discovered_at: 2026-05-14T18:02:39.687486+00:00
generated_at: 2026-05-16T16:53:58.866922+00:00
sec_items: ["1.03", "3.01", "7.01", "9.01"]
event_type: other_material
sentiment: negative
materiality_score: 0.9
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001193125-25-297177
json_url: https://secwatch.observer/filing/0001193125-25-297177.json
markdown_url: https://secwatch.observer/filing/0001193125-25-297177.md
text_url: https://secwatch.observer/filing/0001193125-25-297177.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1539029/000119312525297177/0001193125-25-297177-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1539029/000119312525297177/d41251d8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001193125-25-297177

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.